`
`1 of l
`
`AACR Journals Online
`
`Beginning January 22, 2001, the full text of all AACRjournals will be available online through a partnership
`with Hi gh‘Mre Press, Please explore the resources offered by the following journal sites:
`
`W. Obtain general information about all AACR publications and link to the AACR
`journal sites. Search across all AACR journals.
`
`Cancer Research Online. Access the 1999, 2000, and 2001 volumes in full—text, searchable SGML and in PDF
`
`format. Search the abstracts of every issue of the journal dating back to the 1975 volume. [Please note: While
`the 2000 and 200i volumes will be available in full-text SGML immediately upon launch, the 1999 volume
`will be available in early February!
`
`Clinical Cancer Research Online! Access the 1999, 2000, and 2001 volumes in full-text, searchable SGML and
`in PDF format. Search the abstracts of every issue of the journal dating back to the inaugural 1995 volume.
`[Please note: While the 2000 and 2001 volumes will be available in full-text SGML immediately upon launch,
`the 1999 volume will be available in early February]
`
`Access the l999, 2000, and 2001 volumes in full-text,
`searchable SGML and in PDF format. Search the abstracts of every issue of thejournal dating back to the
`inaugural 1991 volume.
`
`Access the I999, 2000. and 2001 volumes in full-text, searchable
`SGML and in PDF format. Search the abstracts of every issue of the journal dating back to the inaugural 1990
`volume.
`
`After the launch of AACR Journals Online, the joumm sites will be available to the public at no charge through
`the end of February. Beginning March I, 2001, access to the fulletext SGML and PDF versions of each journal
`will be limited to subscribers. However, access to the journal abstracts and the search features will continue to
`be available to the public at no charge.
`
`We encourage everyone to take advantage of this trial period to evaluate the resources offered by AACR
`Journals Online. To subscribe to an AACR journal, contact the AACR Subscription Office [Phone: (800)
`63349“ or (205) 995— 1567; Fax (205) 995-1388].
`
`htlpzl'iwebarchive.orglweb/ZOGl l I03043945/http:/fwwwaacrorngOOO/Z 100/2 l00m.html
`
`AstraZeneca Exhibit 2042 p. 1
`InnoPharma Licensing LLC V. AstraZeneca AB IPR2017-00905
`
`